Partner with Us | The Society of Gynecologic Oncology of Canada (GOC)

The Society of Gynecologic Oncology of Canada (GOC) is a non-profit organization consisting of physicians, nurses, scientists, and other health care professionals specializing in gynecologic oncology.

Its purpose is to improve the care of women with or at risk of gynecologic cancer by raising standards of practice, encouraging ongoing research, promoting innovation in prevention, care, and discovery, and advancing awareness. GOC also seeks to disseminate knowledge to practitioners, patients and the general public on gynecologic cancer as well as cooperate with other organizations committed to women’s health care, oncology, and related fields.

Download the Sponsorship Prospectus

Patient Groups

Ovarian Cancer Canada

Ovarian Cancer Canada champions the health and wellbeing of women with ovarian cancer and others at risk of this disease while advancing research to save lives. As the only registered Canadian charity solely dedicated to overcoming ovarian cancer, the organization provides leadership in research, advocacy, and support, so that women live fuller, better, longer lives.

World Ovarian Cancer Coalition

The World Ovarian Cancer Coalition is a not-for-profit organization, formally established in 2016, working across the globe towards a world where every woman with ovarian cancer has the best chance of survival, and the best quality of life – wherever she may live.

Young Adults Cancer Canada

Our mission is to support young adults living with, through, and beyond cancer. To be the connection to peers, bridge out of isolation, and source of inspiration. Every cancer, every stage, YACC’s got your back.

Medical Societies

Canadian Association of Genetic Counsellors

The Canadian Association of Genetic Counsellors (CAGC) was formed in 1987 with the goal of promoting high standards of practice, facilitating and supporting professional growth and increasing public awareness of the genetic counselling profession in Canada.

Canadian Association of Nurses in Oncology

Established in 1985, the Canadian Association of Nurses in Oncology/Association canadienne des infirmières en oncologie (CANO/ACIO) is a national organization with a mission to advance oncology nursing excellence through practice, education, research, and leadership for the benefit of all Canadians, and a vision of being an international nursing leader in cancer control. We are a member-run association that takes direction from its membership in formulating activities and initiatives.

Canadian Association of Pathologists

The Canadian Association of Pathologists (Association canadienne des pathologistes), a voluntary professional organization, advances the interests of our profession and promotes high quality standards for patient care by providing national leadership and promoting excellence in pathology and laboratory medicine practice, education and research.

A red maple leaf with a blue and white DNA double helix in the center is to the left of the blue text "CCMG CCGM" on a white background.

International Gynecologic Cancer Society

The mission of the International Gynecologic Cancer Society is to enhance the care of those affected by gynecologic cancers worldwide through education and training and public awareness. We achieve our mission through strategic collaborations with regional and international organizations, hosting and supporting scientific meetings, promoting research and publications, outreach, and other activities that:

Raise public awareness of the importance of early recognition and treatment of gynecologic cancers
Connect professionals interested in gynecologic cancers around the world
Support research to achieve optimal care of women with gynecologic malignancies
Provide mentorship, education and training worldwide

The Society of Canadian Colposcopists

The Society of Canadian Colposcopists (SCC) brings together healthcare professionals who have displayed a particular interest in and knowledge of lower genital tract neoplasia and benign disorders and thus are capable of and willing to assist the Society in attaining its goals and objectives.

The Society of Obstetricians and Gynaecologists of Canada

The Canadian Association of Pathologists (Association canadienne des pathologistes), a voluntary professional organization, advances the interests of our profession and promotes high quality standards for patient care by providing national leadership and promoting excellence in pathology and laboratory medicine practice, education and research.

Canadian Association of Pathologists

The SOGC is one of Canada’s oldest national specialty organizations. Established in 1944, the Society’s mission is to lead the advancement of women’s health through excellence and collaborative professional practice. The SOGC has grown to over 4,000 members, comprised of obstetricians, gynaecologists, family physicians, nurses, midwives, and allied health professionals working in the field of women’s sexual and reproductive health.

Other Institutions

Canadian Partnership Against Cancer

We work collaboratively with provincial, territorial and national partners to move Canada’s cancer strategy forward. As the steward of the Canadian Strategy for Cancer Control, we have a unique vantage point—shared with and informed by our partners— that allows us to facilitate collaboration across the cancer community and accelerate work that improves the effectiveness and efficiency of cancer control in Canada.

Canada’s Drug and Health Technology Agency

CADTH believes that credible, objective evidence should inform every important health care decision. When you want to know what the evidence says, ask CADTH. CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies, including:

drugs
diagnostic tests
medical, dental, and surgical devices and procedures.
In addition to evidence, we also provide advice, recommendations, and tools

Journal of Gynecologic Oncology

The Journal of Gynecologic Oncology (JGO) is an official publication of the Asian Society of Gynecologic Oncology, the Korean Society of Gynecologic Oncology, the Japan Society of Gynecologic Oncology, and the Society of Gynecologic Oncology of Canada (GOC). Abbreviated title is ‘J Gynecol Oncol’. It was launched in 1990. The JGO’s aim is to publish the highest quality manuscripts dedicated to the advancement of care of the patients with gynecologic cancer. It is an international peer-reviewed periodical journal that is published bimonthly (January, March, May, July, September, and November). Supplement materials are published at times. The journal publishes editorials, original and review articles, correspondence, book review, etc. Research areas covered by this journal include: epidemiology, prevention, diagnosis, treatment strategies including surgery, chemotherapy, radiotherapy, or combined therapy, clinical trials, quality of life issues, and basic research genetics, immunology, ‘omics’, as well as research from any of the related disciplines. The JGO is indexed/tracked/covered by MEDLINE, PubMed, PubMed Central (PMC), KoreaMed, Synapse, KoMCI, Science Citation Index Expanded (SCIE, Web of Science), Chemical Abstracts Service (CAS), SCOPUS, EMBASE and Google Scholar.

Current Oncology

Current Oncology (ISSN 1718-7729), is dedicated to advancing cancer care and therapy by publishing clinically relevant research with direct applications to oncology practice. The journal is indexed in major databases such as Web of Science and PubMed, and holds an Impact Factor of 3.4 along with a CiteScore of 4.9. Since its establishment in 1994, the journal has played an important role in disseminating new knowledge across the entire cancer care continuum, spanning cancer prevention, early detection and diagnosis, treatment including systemic therapy, radiation therapy, and surgery, supportive care, and survivorship care, while also highlighting the critical role of biomarkers and biomarker-driven research in guiding personalized oncology. Affiliated with several key cancer societies, Current Oncology provides a global platform to share scientific progress in oncology. Current Oncology is led by its Editor-in-Chief, Prof. Dr. Shahid Ahmed at the University of Saskatchewan, Saskatoon, SK, Canada.

Industry

AstraZeneca Canada

AstraZeneca is a science-led biopharmaceutical company pushing the boundaries of science to deliver life-changing medicines.

The company employs roughly 900 people in Canada who work to research, develop and market innovative medicines. AstraZeneca Canada was recently designated a global Clinical Hub for oncology and immuno-oncology clinical studies. We are currently leading global oncology clinical studies in lung, head and neck cancer.

The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following core therapy areas: Cardiovascular, Renal and Metabolic diseases (CVRM); Oncology; and Respiratory & Immunology.

Canopy Growth

Canopy is channeling the power of cannabis to build an organization made with intention and purpose, serving as a new model for an evolving industry. We understand our consumer better than anyone else, and leverage best-in-class insights to steer our innovations, creating industry-leading brands and quality products that consumers love. Our objectives to harness the power of the plant, build a world-class CPG company and cultivate a purpose-driven atmosphere push us to fight for the meaningful changes we know are possible.

Eisai Canada

We give first thought to patients and the people in the daily living domain, and increase the benefits that healthcare provides to them as well as meet their diversified healthcare needs worldwide.

GlaxoSmithKline Canada

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

Black and white line drawing of a lion standing on all fours, with stylized details and the word "LEO" in capital letters beneath the image.

Leo Pharma

LEO Pharma Canada is a division of LEO Pharma A/S, a global research-based pharmaceutical company, specializing in skin health and thrombosis (blood clots). For more than a century across the globe, and for over 30 years in Canada, our focus has been on improving the quality of patients’ lives. We are expanding into new markets, to reach more patients with innovative treatments to address unmet medical needs.

Merck Canada

For over 130 years, Merck Canada has been providing leading innovations and therapies for many of our world’s most challenging diseases in pursuit of our mission to save and improve lives.

Roche Canada

We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world. That is why we come to work each day. We commit ourselves to scientific rigor, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow. We are proud of who we are, what we do, and how we do it. We are many, working as one across functions, across companies, and across the world. We are Roche.

Sanofi Canada

We are Sanofi, a global biopharmaceutical company committed to healthcare solutions from prevention to treatment. We turn scientific discoveries into medicine to improve health. Every day, we dedicate our most important resource, our people, to support patients and families through their health journey.